Introduction {#sec1-1}
============

Integron system is one of the important dynamic mechanisms in the evolution of multidrug resistance (MDR) which helps bacteria to acquire resistance genes in novel combinations enabling them to resist several antimicrobial agents and is frequently associated with the development of MDR in Gram-negative bacteria \[[@ref1]\]. Integrons are capable of capturing and excising gene cassettes.

There are two types of integrons, chromosomal integrons and mobile integrons (MIs). MIs are of five classes - Class 1-5 \[[@ref2]\]. Class 1 integrons, the most common type, mostly found as part of the Tn21 or Tn402 transposon family, have been detected in bacteria in many regions and have been identified as a primary source of antimicrobial resistance (AMR) genes and suspected to serve as reservoirs capable of exchanging resistance genes in a variety of Gram-negative bacteria \[[@ref3],[@ref4]\]. They contain a 5′ conserved segment (5′CS) and a 3′ conserved segment (3′CS) \[[@ref5]\].

The prevalence of integrons in *Salmonella* spp. of avian origin has not been previously reported from India. The present study was conducted with the following objectives: (i) To screen the *Salmonella* spp. isolates recovered from suspected cases of fowl typhoid for carriage of Class 1 integrons and analyze their association with AMR and (ii) to carry out molecular characterization and phylogenetic analysis of integron-integrase (*intI1*) gene.

Materials and Methods {#sec1-2}
=====================

Ethical approval {#sec2-1}
----------------

This study did not involve any live humans or animals and therefore no ethical approval was required.

Isolates {#sec2-2}
--------

Sample collection, isolation, and biochemical characterization of *Salmonella* spp., serotyping, *in vitro* antimicrobial sensitivity patterns of the *Salmonella* isolates to various antimicrobials, and genomic DNA preparation has been described in our previous publication \[[@ref6]\].

Screening of isolates for carriage of Class 1 integrons {#sec2-3}
-------------------------------------------------------

Out of 45 flocks investigated for fowl typhoid, 43 *Salmonella* isolates were analyzed for the presence of Class 1 integrons according to the method previously described \[[@ref7]\], with some modifications (annealing temperature of 56°C used instead of 54°C), using primers *intI1-F "*ACGAGCGCAAGGTTTCGGT" and *intI1-R "*GAAAGGTCTGGTCATACATG."

Statistical analysis {#sec2-4}
--------------------

A 95% confidence interval for carriage of integrons in different serotypes was calculated using STATA™. Differences between different serotypes in relation to their carriage of integrons and the differences between strains containing or not containing an integron and being resistant to different antimicrobials were analyzed by Fisher exact test, using STATA™ (StataCorp, College Station, TX).

Sequencing of intI1 polymerase chain reaction (PCR) products {#sec2-5}
------------------------------------------------------------

Representative PCR products were got sequenced in the university facility using an ABI 3130xL sequencer. The products were got accessioned in GenBank (accession no. MF346348.1, MF346759.1, MF346760.1, and MF346761.1).

Phylogenetic analysis {#sec2-6}
---------------------

The related sequences (23) obtained during the BLAST search were retrieved from GenBank, and multiple sequence alignment was carried along with nucleotide sequences obtained from the present study. All the 27 sequences were aligned by ClustalW in MEGA6 software. The evolutionary history was inferred using the maximum likelihood method based on the Tamura 3-parameter model. Initial tree(s) for the heuristic search was obtained automatically by applying neighbor-join and BioNJ algorithms to a matrix of pairwise distances estimated using the maximum composite likelihood approach and then selecting the topology with superior log-likelihood value. Codon positions included were 1^st^+2^nd^+3^rd^+Noncoding. All positions containing gaps and missing data were eliminated. There were a total of 290 positions in the final dataset. Evolutionary analyses were conducted in MEGA6 using 100 bootstrap replicates \[[@ref8]\].

Results {#sec1-3}
=======

Of the total of 43 *Salmonella* isolates subjected to PCR assay to determine Class1 integron integrase (*intI1*), 40 (93.02%) were found positive for Class 1 integrons ([Figure-1](#F1){ref-type="fig"}). 35/40 (87.5%) *intI1*-positive isolates were MDR (resistant to ≥4 antibiotics).

![Agarose gel showing Class 1 integron integrase (intI1), amplified from *Salmonella* spp. isolates. Lane 1 -- 100 bp DNA ladder; Lanes 2-10 -- amplicons from *Salmonella* spp. isolates.](VetWorld-12-609-g001){#F1}

There was no significant difference among isolates resistant to different antimicrobials in Class 1 integron carrying isolates and the Class 1 integron negative isolates (p\<0.05) ([Table-1](#T1){ref-type="table"}). Further, there was no significant difference among different serotypes in respect of their carriage of Class 1 integrons ([Table-2](#T2){ref-type="table"}).

###### 

Number of *Salmonella* isolates with or without Class 1 integron in relation to their resistance toward different antimicrobials.

  Antibiotics                      Total number of resistance isolates   Class 1 Integron-positive isolates (n=40) (%)   Class 1 Integron-negative isolates (n=3) (%)
  -------------------------------- ------------------------------------- ----------------------------------------------- ----------------------------------------------
  b-lactams                                                                                                              
   Ampicillin                      2                                     2 (5.0)                                         0 (-)
   Carbenicillin                   4                                     3 (7.5)                                         1 (33.3)
   Cefotaxime                      3                                     3 (7.5)                                         0 (-)
  Aminoglycosides                                                                                                        
   Gentamicin                      7                                     7 (17.5)                                        0 (-)
   Kanamycin                       3                                     2 (5.0)                                         1 (33.3)
   Streptomycin                    4                                     4 (10.0)                                        0 (-)
   Spectinomycin                   10                                    10 (25.0)                                       0 (-)
  Chloramphenicol                                                                                                        
   Chloramphenicol                 0                                     0 (-)                                           0 (-)
  Tetracyclines                                                                                                          
   Tetracycline                    16                                    14 (35.0)                                       2 (66.7)
  Sulfonamides                                                                                                           
   Co-trimoxazole                  13                                    12 (30.0)                                       1 (33.3)
   Sulfafurazole                   27                                    25 (62.5)                                       2 (66.7)
  Quinolones and fluoroquinolone                                                                                         
   Ciprofloxacin                   39                                    37 (92.5)                                       2 (66.7)
   Enrofloxacin                    32                                    30 (75.0)                                       2 (66.7)
   Norfloxacin                     32                                    30 (75.0)                                       2 (66.7)
   Nalidixic acid                  41                                    38 (95.0)                                       3 (100)

###### 

Number of isolates of different serotypes in relation to their carriage of Class 1 integrons.

  Serovar                    Total number of isolates   Class 1 Integron-positive isolates   
  -------------------------- -------------------------- ------------------------------------ ---------------------
  *Salmonella* Gallinarum    34                         31                                   91.18 (76.3-98.0)
  *Salmonella* Typhimurium   5                          5                                    100.00 (47.8-100.0)
  *Salmonella* Enteritidis   2                          2                                    100.00 (15.8-100.0)

Phylogenetic tree derived by analyzing and comparing the *intI1* gene sequences obtained from the current study and the published NCBI sequences is illustrated in [Figure-1](#F1){ref-type="fig"}. Neighbor-joining phylogenetic tree indicated two distinct clads: First clad comprising all of the four isolates of the current study and almost all other isolates retrieved for analysis and the second clad comprising two isolates: *Salmonella* Brandenburg (NC 010500.1/0) from Spain and *Salmonella* Typhimurium (JQ345502.1) from Hungary ([Figure-2](#F2){ref-type="fig"}).

![The evolutionary history of *intI1* inferred using the neighbor-joining method. The evolutionary distances were computed using the maximum composite likelihood method. The analysis involved 27 nucleotide sequences. The tree with the highest log likelihood (−879.2015) is shown. The tree is drawn to scale, with branch lengths measured in the number of substitutions per site.](VetWorld-12-609-g002){#F2}

Discussion {#sec1-4}
==========

Of the total of 43 *Salmonella* isolates subjected to PCR assay to determine Class1 integron integrase (*intI1*), 40 (93.02%) were found positive for Class 1 integrons. 35/40 (87.5%) *intI1*-positive isolates were MDR (resistant to ≥4 antibiotics). The prevalence of integrons in *Salmonella* varies from country to country and depends on the origin of the isolates as discussed below.

There are different reports of the prevalence of Class 1 integrons in *Salmonella* isolates from different parts of the world. The Overall high positive rate of 66.5% of Class 1 integrons in multidrug-resistant *Salmonella enterica* serovar Indiana (87.2%) and Enteritidis (50.8%) isolated from chickens in Eastern China has been reported \[[@ref9]\]. Class 1 integrons were present in 35 strains (38%) of biotype *gallinarum* (90 strains) isolated from chickens in Korea \[[@ref10]\]. The *intI1* gene was present in 31% of the *Salmonella* isolates from broiler chickens, pigs, and meat products in Thailand and Cambodia \[[@ref11]\]. The prevalence of Class 1 integrons in *Salmonella* isolates from humans and animals in Vietnam was found to be 28% \[[@ref12]\], whereas, in China, Class 1 integrons were detected in 10/62 (16.13%) *Salmonella* isolates from different retail foods \[[@ref9]\]. A high prevalence of Class 1 integron in drug-resistant *Salmonella enterica* serovar Enteritidis isolates of poultry origin from Iran (17/30, 56.66%) has also been reported \[[@ref13]\].

In our study, there was no significant difference among isolates resistant to different antimicrobials in Class 1 integron carrying isolates and the Class 1 integron negative isolates (p\<0.05). Further, there was no significant difference among different serotypes in respect of their carriage of Class 1 integrons.

In contrast, a significant relation was found for the presence of Class 1 integrons and resistance to trimethoprim, sulfonamides, and tetracycline in *Escherichia coli* isolated form laying hens in Belgium \[[@ref7]\]. Similarly, *Salmonella* isolates (recovered from retail raw chicken carcasses in China), harboring Class I integrin, presented a significantly (p\<0.05) higher resistance to tetracycline, ampicillin, trimethoprim-sulfamethoxazole, amoxicillin-clavulanic acid, chloramphenicol, kanamycin, gentamicin, ceftiofur, cefoxitin, and amikacin compared with the average resistance rates \[[@ref14]\]. The resistance of *E. coli* isolates toward sulfafurazole, trimethoprim, streptomycin, gentamicin, kanamycin, tobramycin, chloramphenicol, and amoxicillin was found to be associated with integron existence \[[@ref15]\]. Similarly, another study has shown resistance against sulfonamides, trimethoprim, streptomycin, chloramphenicol, amoxicillin, tetracycline, and neomycin to be associated with integron existence \[[@ref16]\]. Differences between *intI1-*positive and *intI1-*negative isolates in resistance to gentamicin, streptomycin, aminosidine, triple sulfonamides, and trimethoprim combined with sulfamethoxazole have been suggested to be significantly higher in *intI1*-positive compared with *intI1*-negative isolates \[[@ref17]\]. This non-significant difference can be due to a lower number of isolates (3/43) without integrons obtained in this study. In our study, 35/40 (87.5%) *intI1*-positive isolates were MDR (resistant to ≥4 antibiotics) which support the hypothesis of an association between the occurrence of Class 1 integrons and emerging MDR in *Salmonella*.

The outcome of phylogenetic analyses interprets the genetic similarity of *Salmonella* isolates of the current isolates to other isolates from different parts of the world, including India ([Figure-2](#F2){ref-type="fig"}).

Conclusion {#sec1-5}
==========

Based on our studies, we can conclude that the high prevalence of Class 1 integrons indicates the high potential of isolates for horizontal transmission of antimicrobial genes, especially among Gram-negative organisms. Further, elaborate study with more number of isolates would statistically improve our understanding about the role of this mechanism of resistance toward different antimicrobials, thus formulating targeted strategies for the amelioration of AMR.
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